Search

everythinglearnresearchcommunity

for

Search:↓

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

UVB exposure affects retinoid metabolism, which is important for skin cancer progression and treatment.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

Low zinc levels may be linked to the return of gynecologic cancers.

Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

Computational methods help design drugs targeting prostate cancer proteins.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

DNA microarrays help study skin diseases and biology, leading to advancements in understanding and treatment.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

The treatment process effectively removes many pollutants from cosmetics wastewater, but more research is needed to improve it.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Mohs surgery effectively treats nipple adenoma while preserving the nipple area.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.